Expressing Concerns to Moderna’s Principal Investigators


Letter by Harold R Gielow, LtCol USMC (Ret)

 

Recently, Harold R Gielow, LtCol USMC (Ret) sent an email to the principal investigators in Moderna’s mRNA 1273 phase 3 trial outlining his concerns. He has yet to receive a reply.

“The article “Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population” notes that approximately 72% of the US population has preexisting anti-PEG antibodies.  The reference further states, “…sensitive detection and precise quantitation of anti-PEG Ab levels in a clinical setting will be essential to ensuring the safe use of PEGylated drugs in all target patient populations going forward.”

As Moderna’s mRNA1273 candidate vaccine uses a pegylated LNP (lipid nanoparticle) vector , what procedures are included in the trial to mitigate this risk?”

Our country is spending billions to fast track and produce a vaccine that over 70% of the population has preexisting antibodies to – to the vaccine!  This makes no sense.  Additionally, the trial procedures I have read include no steps to mitigate this risk, either to the trial participants or the general public.

BioNTech/Pfizer’s vaccine variants also use a pegylated lipid nanoparticle vector.

… many with PEG hypersensitivity go undiagnosed, thus presenting an unreasonable hazard to administering these vaccines to a population, the vast majority of which is proven by science to have anti-PEG antibodies.

I have a severe anaphylactic response to polyethylene glycol.  It was diagnosed by Johns Hopkins.  I have had multiple ambulance rides and emergency room visits due to inadvertent ingestion/injection with medications containing polyethylene glycol.  It is classified by FDA as biologically inert/inactive.  It is anything but that. The incidences of hypersensitivity reactions to PEG are, understandably, increasing, although many with PEG hypersensitivity go undiagnosed, thus presenting an unreasonable hazard to administering these vaccines to a population, the vast majority of which is proven by science to have anti-PEG antibodies. The cited study used blood samples from 1990-1999.  The study showed a steady and dramatic increase in anti-PEG antibodies over time.

PEG is ubiquitous in our environment.  It is nearly impossible to avoid, more so as our government classifies it as biologically inactive.

I have communicated my concern to my congressman, my senator, FDA, NIH, the White House, a cousin in biomedical research, multiple scientific writers, and countless others.  Perhaps with your background and profile, you can get attention on this issue.  I frankly believe not mitigating this risk in a worldwide pandemic situation is gross negligence, Moderna’s scientists having contributed to scientific studies pointing out these issues with polyethylene glycol.”

The post Expressing Concerns to Moderna’s Principal Investigators appeared first on Children's Health Defense.

© 03 Aug 2020 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

0 0 vote
Article Rating

Support Children's Health Defense

DONATE HERE

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

More from Children's Health Defense: